A. J. Lewis and A. M. Manning. New targets for anti-inflammatory drugs. Curr. Opin. Chem. Biol.
M. J. Suto and L. Ransone. Novel approaches for the treatment of inflammatory diseases: inhibitors of NF-κB and AP-1. Current Pharm. Design
A. O'Garra and N. Arai. The molecular basis of T helper 1 and T helper 2 cell differentiation. Rev. Trends Cell. Biol.
A. Tsuboi, M. Muramatsu, A. Tsusumi, K. Arai, and N. Arai. Calcineurin activates transcription from the GM-CSF promoter in synergy with either protein kinase C or NF-kappa B/AP-1 in T cells. Biochem. Biophys. Res. Commun.
S. Gerondakis, M. Grossmann, Y. Nakamura, T. Pohl, and R. Grumont. Genetic approaches in mice to understand Rel/NFkappaB and IkappaB function: transgenics and knockouts. Oncogene 18:6888–6895 (1999).
K. K. Mann, S. Doerre, J. J. Schlezinger, D. H. Sherr, and S. Quadri. The role of NF-kappaB as a survival factor in environmental chemical-induced pre-B cell apoptosis. Mol. Pharmacol.
C. A. Heid, J. Stevens, K. J. Livak, and P. M. Williams. Real time quantitative PCR. Genome Res.
R. Luthra, J. A. McBridge, F. Cabanillas, and A. Sarris. Novel 5' exonuclease-based real-time PCR assay for the detection of t(14;18)(q32;q21) in patients with follicular lymphoma. Am. J. Pathol.
T. Takenouchi and E. Munekata. Trophic effects of substance P and beta amyloid peptide on dibutyryl cyclic AMP-differentiated human leukemic (HL60) cells. Life Sci.
V. F. Quesniaux. Immunosuppressants; tools to investigate the physiological role of cytokines. Bioassays
D. Piomelli. The ligand that came from within. Trends Pharmacol. Sci.
Y. Surh. Molecular mechanism of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat. Res.
Y. J. Surh, S. S. Han, Y. S. Keum, H. J. Seo, and S. S. Lee. Inhibitory effects of curcumin and capsaicin on phorbol esterinduced activation of eukaryotic transcription factors, NFkappaB and AP-1. Biofactors
J. Barnes, L. A. Anderson, and J. D. Phillipson. St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties. J. Pharm. Pharmacol.
C. M. Schempp, B. Simon-Haarhaus, C. C. Termeer, and J. C. Simon. Hypericin photo-induced apoptosis involves the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and activation of caspase-8. FEBS Lett.
P. M. Bork, S. Bacher, M. L. Schmitz, U. Kaspers, and M. Heinrich. Hypericin as a non-antioxidant inhibitor of NF-kappa B. Planta Med.
R. F. Anderson, L. J. Fisher, Y. Hara, T. Harris, W. B. Mak, L. D. Melton, and J. E. Packer. Green tea catechins partially protect DNA from OH radical-induced strand breaks and base damage through fast chemical repair of DNA radicals. Carcinogenesis
K. M. Riedl and A. E. Hagerman. Tannin-protein complexes as radical scavengers and radical sinks. J. Agric. Food Chem.
49: 4917–4923 (2001).
U. E. Gibson, C. A. Heid, and P. M. Williams. A novel method for real time quantitative RT-PCR. Genome Res.
T. Lindl. Zell-und Gewebekultur, 4. Edition, Spektrum Akademischer Verlag, Berlin, 2000.
C. S. Sun, P. A. Ganchi, D. W. Ballard, and W. C. Greene. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science
O. Silvennoinen. Immunodeficiencies and haematological disorders, direct connections to cellular signalling pathways. Rev. Ann. Med.
K. J. Hardy, B. Manger, M. Newton, and J. D. Stobo. Molecular events involved in regulating human interferon-gamma gene expression during T cell activation. J. Immunol.
A. Weiss, R. L. Wiskocil, and J. D. Stobo. The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL-2 production reflects events occurring at a pretranslational level. J. Immunol.
R. L. Wiskocil, A. Weiss, J. Imbodden, R. Kamin-Lewis, and J. D. Stobo. Activation of a human T cell line: a two-stimulus requirement in the pretranslational events involved in the coordinate expression of interleukin 2 and gamma-interferon genes. J. Immunol.
O. Bill, C. G. Garlisi, D. S. Grove, G. E. Holt, and A. M. Maestro. IL-2 mRNA levels and degradation rates change with mode of stimulation and phorbol ester treatment of lymphocytes. Cytokine
V. Depraetere and P. Goldstein. Fas and other cell death signaling pathways. Review. Semin. Immunol.
R. Wang, L. Zhang, D. Yin, R. A. Mufson, and Y. Shi. Protein kinase C regulates Fas (CD95/APO-1) expression. J. Immunol.
C. C. Wilhide, C. van Dang, J. Dispersio, A. A. Kenedy, and P. F. Bray. Overexpression of cyclin D1 in the Dami megakaryocytic cell line causes growth arrest. Blood
F. Ajchenbaum, K. Ando, J. A. De Caprio, and J. D. Griffin. Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes. J. Biol. Chem.
A. K. Khanna and J. D. Hosenpud. In vitro and in vivo transfection of p21 gene enhances cyclosporin A-mediated inhibition of lymphocyte proliferation. J. Immunol.
A. K. Khanna and J. D. Hosenpud. Cyclosporine induces the expression of the cyclin inhibitor p21. Transplantation